quinazolines has been researched along with Liver Failure in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (62.50) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bijarnia, M; De Simone, P; Isoneimi, H; Klupp, J; Krishnan, I; Pascher, A; Pirenne, J; Pratschke, J; Salamé, E | 1 |
| Levy, G; Trotter, JF | 1 |
| Saif, MW | 1 |
| Han, C; Isse, K; Li, G; Lim, K; Wu, T; Xu, L | 1 |
| An, SJ; Chen, ZH; Huang, YS; Wu, YL | 1 |
| Abu-Khalaf, M; Gunturu, KS; Saif, MW | 1 |
| Fiebiger, W; Raderer, M; Scheithauer, W; Wrba, F | 1 |
1 trial(s) available for quinazolines and Liver Failure
| Article | Year |
|---|---|
Protein kinase C inhibitor sotrastaurin in de novo liver transplant recipients: a randomized phase II trial.
Topics: Adult; Aged; Biopsy; Enzyme Inhibitors; Female; Glomerular Filtration Rate; Graft Rejection; Humans; Immunosuppressive Agents; Incidence; Kaplan-Meier Estimate; Kidney Transplantation; Liver Failure; Liver Transplantation; Male; Middle Aged; Protein Kinase C; Pyrroles; Quinazolines; Tacrolimus; Time Factors; Treatment Outcome | 2015 |
7 other study(ies) available for quinazolines and Liver Failure
| Article | Year |
|---|---|
Sotrastaurin in liver transplantation: has it had a fair trial?
Topics: Enzyme Inhibitors; Female; Humans; Liver Failure; Liver Transplantation; Male; Protein Kinase C; Pyrroles; Quinazolines | 2015 |
Hepatic failure and hepatorenal syndrome secondary to erlotinib. Safety reminder.
Topics: Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Erlotinib Hydrochloride; Hepatorenal Syndrome; Humans; Liver Failure; Product Surveillance, Postmarketing; Protein Kinase Inhibitors; Quinazolines | 2008 |
Cyclooxygenase-2 prevents fas-induced liver injury through up-regulation of epidermal growth factor receptor.
Topics: Animals; Apoptosis; Chemical and Drug Induced Liver Injury; Cyclooxygenase 2; ErbB Receptors; fas Receptor; Fas-Associated Death Domain Protein; Hepatocytes; Liver; Liver Failure; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Nitrobenzenes; Quinazolines; Sulfonamides; Tyrphostins; Up-Regulation | 2009 |
Three cases of severe hepatic impairment caused by erlotinib.
Topics: Adenocarcinoma; Adult; Aged; Biopsy; Erlotinib Hydrochloride; Fatal Outcome; Humans; Liver Failure; Liver Function Tests; Male; Middle Aged; Protein Kinase Inhibitors; Quinazolines | 2009 |
Erlotinib: potentially fatal in cases of liver failure: a contraindication.
Topics: Contraindications; ErbB Receptors; Erlotinib Hydrochloride; Humans; Liver Failure; Neoplasms; Protein Kinase Inhibitors; Quinazolines | 2009 |
Hepatic failure and hepatorenal syndrome secondary to erlotinib: a possible etiology of complications in a patient with pancreatic cancer.
Topics: Adenocarcinoma; Adult; Antineoplastic Agents; Erlotinib Hydrochloride; Fatal Outcome; Hepatorenal Syndrome; Humans; Liver Failure; Male; Pancreatic Neoplasms; Quinazolines | 2010 |
Fatal liver failure after the administration of raltitrexed for cancer chemotherapy: a report of two cases.
Topics: Aged; Antimetabolites, Antineoplastic; Fatal Outcome; Female; Humans; Liver Failure; Male; Middle Aged; Neoplasms; Quinazolines; Thiophenes | 2000 |